Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 16, 2011
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South AfricaElizabeth M Streicher, Borna Müller, Violet Chihota, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in TanzaniaErasto V Mbugi, Bugwesa Z Katale, Keith K Siame, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|July 8, 2011
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosisFrederick A Sirgel, Marisa Tait, Robin M Warren, et al.
Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort studyTuelo Mogashoa, Justice T Ngom, Ontlametse T Choga, et al.
Plos One|September 24, 2013
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaBorna Müller, Violet N Chihota, Manormoney Pillay, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Journal of Infection and Public Health|February 11, 2026
High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort studyTuelo Mogashoa, Justice T Ngom, Ontlametse T Choga, et al.
Plos One|May 6, 2016
Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesErasto V Mbugi, Bugwesa Z Katale, Elizabeth M Streicher, et al.
Ebiomedicine|February 26, 2025
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkersAmandine Sury, Margo Maex, Alain Baulard, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.
Pageof 8